Gene amplification refers to a number of natural and artificial processes by which the number of copies of ageneis increased "without a proportional increase in other genes".
Gene Amplification Technologies Market contains market size and forecasts of Gene Amplification Technologies in Global, including the following market information:
- Global Gene Amplification Technologies Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global top five companies in 2021 (%)
The global Gene Amplification Technologies market was valued at 3710.8 million in 2021 and is projected to reach US$ 7027 million by 2028, at a CAGR of 9.6% during the forecast period.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
Polymerase Chain Reaction (PCR) Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Gene Amplification Technologies include Abbott Laboratories, QIAGEN, Agilent Technologies, Bayer Corporation, Rubicon Genomics, BD, Roche Diagnostics, BioMerieux and Bio-Rad Laboratories, etc. In 2021, the global top five players have a share approximately % in terms of revenue.
We surveyed the Gene Amplification Technologies companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Gene Amplification Technologies Market, by Type, 2017-2022, 2023-2028 ($ millions)
Global Gene Amplification Technologies Market Segment Percentages, by Type, 2021 (%)
- Polymerase Chain Reaction (PCR)
- Loop Mediated Isothermal Amplification (LAMP)
- Other
Global Gene Amplification Technologies Market, by Application, 2017-2022, 2023-2028 ($ millions)
Global Gene Amplification Technologies Market Segment Percentages, by Application, 2021 (%)
- Medical
- Forensics
- Paternity
- Personnel Identification
- Food safety
- Other
Global Gene Amplification Technologies Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions)
Global Gene Amplification Technologies Market Segment Percentages, By Region and Country, 2021 (%)
- North America
- US
- Canada
- Mexico
- Europe
- Germany
- France
- U.K.
- Italy
- Russia
- Nordic Countries
- Benelux
- Rest of Europe
- Asia
- China
- Japan
- South Korea
- Southeast Asia
- India
- Rest of Asia
- South America
- Brazil
- Argentina
- Rest of South America
- Middle East & Africa
- Turkey
- Israel
- Saudi Arabia
- UAE
- Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
- Key companies Gene Amplification Technologies revenues in global market, 2017-2022 (estimated), ($ millions)
- Key companies Gene Amplification Technologies revenues share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
- Abbott Laboratories
- QIAGEN
- Agilent Technologies
- Bayer Corporation
- Rubicon Genomics
- BD
- Roche Diagnostics
- BioMerieux
- Bio-Rad Laboratories
- Cepheid
- Life Technologies
- Takara Bio
Industry Market Size
